共 50 条
- [1] Hypofractionated intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S315 - S315
- [2] Long Term Outcomes with Hypofractionated Radiotherapy (HFRT) for Clinically Localized Prostate Cancer: 70 Gy at 2.5 Gy per Fraction [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S53 - S53
- [3] Hypofractionated Intensity Modulated Radiation Therapy (63 Gy at 3 Gy per fraction) for Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E209 - E209
- [4] Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (05): : 1424 - 1430
- [5] Relapse-free survival with escalating external beam radiation doses in the treatment of localized prostate cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and hypofractionated 70 Gy at 2.5 Gy per fraction [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S331 - S331
- [6] Hypofractionated intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Long-term outcomes [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1463 - 1468
- [7] Hypofractionated intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcome results [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S124 - S125
- [9] Evaluation of a Hypofractionated Intensity-Modulated Radiation Therapy Scheme (45 Gy at 5 Gy per fraction) in the Treatment of Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E252 - E253
- [10] Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 553 - 566